[
  {
    "ts": "2026-02-13T10:19:53+00:00",
    "headline": "H.C. Wainwright Bullish on ​Genmab A/S (GMAB) on Robust Sales for DARZALEX",
    "summary": "​Genmab A/S (NASDAQ:GMAB) is one of the High Growth International Stocks to Buy Now. On January 28, H.C. Wainwright reiterated a Buy rating on Genmab A/S (NASDAQ:GMAB) and maintained a $39 price target. The rating follows robust net sales of DARZALEX in 2025. ​The company on January 21 reported a significant increase in net sales […]",
    "url": "https://finance.yahoo.com/news/h-c-wainwright-bullish-genmab-101953331.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "af7b30e9-184b-35f7-9913-28a9fa9d2b61",
      "content": {
        "id": "af7b30e9-184b-35f7-9913-28a9fa9d2b61",
        "contentType": "STORY",
        "title": "H.C. Wainwright Bullish on ​Genmab A/S (GMAB) on Robust Sales for DARZALEX",
        "description": "",
        "summary": "​Genmab A/S (NASDAQ:GMAB) is one of the High Growth International Stocks to Buy Now. On January 28, H.C. Wainwright reiterated a Buy rating on Genmab A/S (NASDAQ:GMAB) and maintained a $39 price target. The rating follows robust net sales of DARZALEX in 2025. ​The company on January 21 reported a significant increase in net sales […]",
        "pubDate": "2026-02-13T10:19:53Z",
        "displayTime": "2026-02-13T10:19:53Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/92ad993b23d1981cda76510cabc277ab",
          "originalWidth": 1456,
          "originalHeight": 816,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/V1OWmCXiS8LnmGn5E4BtEQ--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/92ad993b23d1981cda76510cabc277ab.cf.webp",
              "width": 1456,
              "height": 816,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/FWwGn7BFzbQphqwsKW5kbw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/92ad993b23d1981cda76510cabc277ab.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/h-c-wainwright-bullish-genmab-101953331.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/h-c-wainwright-bullish-genmab-101953331.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GMAB"
            },
            {
              "symbol": "GNMSF"
            },
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]